Skip to main content
. 2016 Dec 21;292(2):365–383. doi: 10.1007/s00438-016-1277-x

Table 1.

Cell cycle progression of control and patient fibroblasts as studied by FACS analysis

Control Patient P values
G0/G1 phase 78.16 ± 4.95 84.8 ± 3.59 0.3185
S phase 11.85 ± 3.01 8.80 ± 2.24 0.4473
M phase 6.98 ± 1.57 3.75 ± 0.34 0.0958

The data are mean values in percent derived from four independent experiments. The differences were not statistically significant (two-tailed P values)